New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2014
11:12 EDTTSRA, SGMO, XPO, NWL, NVSHigh option volume stocks: SGMO NVS XPO TSRA NWL
News For SGMO;NVS;XPO;TSRA;NWL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 1, 2015
13:02 EDTXPOXPO Logistics management to meet with BB&T
Meeting to be held in Toronto on April 8 hosted by BB&T.
March 31, 2015
09:50 EDTNVSMylan launches generic Exforge tablets in U.S.
Subscribe for More Information
March 30, 2015
17:46 EDTNVSNovartis announces FDA approval for Jadenu
Subscribe for More Information
05:18 EDTNVSNovartis enters multiyear aliance with Aduro Biotech
Subscribe for More Information
March 26, 2015
11:13 EDTNVSBofA/Merrill European pharma analyst holds an analyst/industry conference call
Subscribe for More Information
10:18 EDTNVSHigh option volume stocks
High option volume stocks: BTX ALL FIVE SGYP SWFT RHT IDCC NVS WGO XBI
March 25, 2015
11:22 EDTXPOXPO Logistics management to meet with Jefferies
Subscribe for More Information
11:20 EDTXPOXPO Logistics management to meet with FBR Capital
Meetings to be held in Milwaukee on March 31 and in Minneapolis on April 1 hosted by FBR Capital.
07:16 EDTSGMOPiper Jaffray and the Alliance for Regenerative Medicine co-host conference
3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link
March 24, 2015
16:31 EDTNWLStamps.com intends to acquire Endicia from Newell Rubbermaid for $215M in cash
Stamps.com (STMP) announced that it has entered into a definitive agreement with Newell Rubbermaid (NWL) for Stamps.com to acquire Endicia, a wholly owned subsidiary of Newell Rubbermaid, for $215M in cash. Based in Palo Alto, California, Endicia is a leading provider of high volume shipping technologies and solutions for use with the U.S. Postal Service and other postal partners. Endicia offers solutions that help businesses run their shipping operations more smoothly and function more successfully. Endicia sells its products under brand names including Endicia, DYMO Stamps and PictureItPostage. Endicia also provides seamless access to USPS and other shipping services through integration with more than 250 partner applications. Endicia had approximately $59M in revenue during fiscal 2014.
11:05 EDTNVSNovartis granted orphan status for medulloblastoma treatment
Subscribe for More Information
March 23, 2015
09:45 EDTNVSUBS to hold a field trip
Subscribe for More Information
09:03 EDTNVSLeerink analysts hold a meeting with a conference call hookup
Subscribe for More Information
March 20, 2015
12:33 EDTNVSNovartis says CLEAR Phase IIb study met primary endpoint
Novartis announced results from the CLEAR study demonstrating that Cosentyx is significantly superior to Stelara, a widely used biologic, in achieving clear or almost clear skin for psoriasis patients. The detailed findings were presented in a late-breaking research session at the 73rd Annual Meeting of the American Academy of Dermatology in San Francisco, USA. Cosentyx -- at a dose of 300 mg -- is the first and only interleukin-17A inhibitor approved to treat adult patients with moderate-to-severe plaque psoriasis. In this Phase IIIb study, Cosentyx met the primary endpoint of showing superiority to Stelara as assessed by the Psoriasis Area Severity Index 90 response, known as clear to almost clear skin at Week 16. PASI 90 is considered an important measure of treatment success by the European Medicines Agency and an optimal treatment goal for patients. In addition, completely clear skin at Week 16 was achieved by significantly more patients treated with Cosentyx than those receiving Stelara. In addition, Cosentyx demonstrated rapid onset of action and greater efficacy at all time points in the study up to Week 16, with 50% of Cosentyx patients achieving PASI 75 as early as Week 4 compared to Stelara. The CLEAR study follows the pivotal Phase III FIXTURE study, which showed Cosentyx was superior to Enbrel.
10:07 EDTNWLHigh option volume stocks
Subscribe for More Information
07:41 EDTNVSAmerican Academy of Dermatology to hold annual meeting
Subscribe for More Information
07:05 EDTNWLGraco to pay $3M fine for delayed reporting, to invest $7M in child safety
Graco Children's Products, a subsidiary of Newell Rubbermaid, has reached an agreement with the National Highway Traffic Safety Administration in connection with the company's reporting of consumer complaints about difficulty opening car seat buckles. As part of the agreement, the company agrees to pay a $3M fine and invest $7M in child passenger safety programs and education.
March 19, 2015
15:55 EDTNVSAmgen injunction bid for Neupogen biosimilar denied, Reuters reports
Subscribe for More Information
15:13 EDTNVSAmgen denied preliminary injunction for biologics against Novartis, Reuters says
10:21 EDTXPOXPO Logistics management to meet with Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use